FUJIMORI YOSHIAKI
SEC insider (Form 3/4/5 filer). CIK 0001233160. Director at TAKEDA PHARMACEUTICAL CO LTD (TAK) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 3, 2025. Located in MARLBOROUGH, MA.
Companies FUJIMORI YOSHIAKI has filed insider reports for
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director
- Blaize Holdings, Inc. (BZAI): Director
- BOSTON SCIENTIFIC CORP (BSX): Director
FUJIMORI YOSHIAKI
CIK: 0001233160
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 3, 2025BZAI
Blaize Holdings, Inc.
AwardDirect75.3K shares- - Jul 29, 2025BSX
BOSTON SCIENTIFIC CORP
SaleDirect2.9K shares at avg. $106.99$310K - Jun 28, 2025BZAI
Blaize Holdings, Inc.
AwardDirect94.4K shares- - May 8, 2025BSX
BOSTON SCIENTIFIC CORP
AwardDirect2.1K shares-
1-4 of 4 transactions